NEU neuren pharmaceuticals limited

Ann: 2023 Results webinar, page-40

  1. 1,423 Posts.
    lightbulb Created with Sketch. 378
    he did mention to the effect of 'shareholders and financials are a very important part of the consideration when it comes to the pathways'. You can argue that it's an investor call and he had to say that but I do think that Neuren management on its own is not going to be able to carry out potentially 4 phase 3 trials at the same time while exploring other potential indications as he pointed out
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$12.54
Change
0.280(2.28%)
Mkt cap ! $1.567B
Open High Low Value Volume
$12.52 $12.73 $12.26 $8.152M 652.1K

Buyers (Bids)

No. Vol. Price($)
1 665 $12.50
 

Sellers (Offers)

Price($) Vol. No.
$12.54 1134 9
View Market Depth
Last trade - 16.10pm 24/06/2025 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.